They should normalise smaller, routine dependency updates instead of waiting for large, risky change events. That approach reduces release pressure, shortens approval work when a real fix is needed, and makes it easier to keep older applications aligned with current security expectations.
Why dependency updates should be governed as a routine change process
Medical software portfolios stay safer when dependency updates are treated as small, regular changes rather than rare, high-stakes events. That governance model reduces batch risk, keeps approval paths familiar, and avoids the operational cliff where one urgent patch must be forced through an outdated release process. It also helps older applications remain supportable as security expectations move forward.
The practical distinction is not between “secure” and “unsafe” updates, but between controlled cadence and accumulated technical debt. When teams defer change, they usually increase regression risk, create larger testing surfaces, and make the eventual security fix harder to approve. Routine updates create more predictable release mechanics and make exceptions easier to justify when they are genuinely necessary.
For medical software, that regular cadence matters because update governance must fit operational continuity as well as assurance. A dependency change may be technically modest but still affect clinical workflows, device integration, or validation evidence, so the governance model should distinguish ordinary maintenance from higher-risk functional change. The goal is to make low-impact updates normal enough that teams do not wait for a crisis before acting.
What good governance looks like in a medical software portfolio
Good governance starts with classifying dependency updates by expected impact, not by release size. Small version bumps, security-only upgrades, and low-risk transitive dependency refreshes should follow a lighter approval path than changes that alter runtime behaviour, interoperability, or regulated functionality. That keeps the process proportional and prevents the board or change forum from becoming a bottleneck for routine maintenance.
A mature portfolio process also sets a service-level expectation for dependency freshness. Teams should know which applications may trail temporarily because of clinical validation constraints, and which ones must stay within a tighter supported window because the surrounding risk is higher. OpenSSF is useful here as a broader reference point for supply-chain hygiene and dependency management practices.
Normalisation is strongest when it is backed by repeatable evidence: inventory of dependencies, clear ownership, and release paths that do not depend on ad hoc heroics. In mixed portfolios, this often means pairing a central policy with application-level risk decisions, so teams can move routine packages quickly while escalating only when a dependency touches sensitive data, safety-relevant behaviour, or a tightly coupled integration.
How to make update governance practical instead of punitive
The most effective approach is to make the default answer “approve small updates unless a specific risk is identified.” That reverses the usual pattern where everything waits for full scrutiny. For a medical software estate, the highest value is often in reducing backlog, because obsolete dependencies silently increase exposure while giving teams the false comfort of stability.
Routine updates are also easier to govern when the release train includes predictable windows for dependency refresh, automated testing, and rollback evidence. The point is not to eliminate human review, but to reserve detailed review for changes that materially alter behaviour. When a package update only changes a dependency version and passes known test gates, the governance decision should be quick and explicit.
Teams should also track the age of pinned dependencies and the number of releases since last refresh, because those signals reveal where governance has drifted into postponement. If an application cannot absorb small updates for months at a time, that is usually a portfolio health issue, not a one-off exception. In that situation, the governance question is whether the application needs a remediation pathway, not whether the next urgent fix should be delayed again.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
CIS Controls v8, SLSA, NIST CSF 2.0 and OWASP ASVS set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| CIS Controls v8 | CIS-4 — Secure Configuration of Enterprise Assets and Software | Routine dependency governance depends on keeping software configurations current and controlled. |
| Recommendation — Standardise dependency update baselines and track drift so small updates stay routine. | ||
| SLSA | Supply Chain Levels for Software Artifacts | Dependency updates in software portfolios are part of software supply-chain integrity and artifact trust. |
| Recommendation — Require provenance and integrity checks before promoting dependency updates into release pipelines. | ||
| NIST CSF 2.0 | PR.IP-1 — Policies and Processes for Protection | Governing dependency updates requires repeatable change processes and defined maintenance policy. |
| Recommendation — Define a maintenance policy that makes routine dependency refreshes a standard operating process. | ||
| ISO/IEC 27001:2022 | A.8.9 — Configuration management | Dependency versions are configuration items that need controlled change and traceability. |
| Recommendation — Record dependency versions as controlled configuration items and review changes on a defined cadence. | ||
| OWASP ASVS | V13 — Configuration | Dependency governance is part of secure configuration and controlled application change. |
| Recommendation — Verify that application build and deployment settings support safe, repeatable dependency updates. | ||
Practitioner Guidance
What to prioritise: Prioritise shortening the path for low-risk dependency updates before tightening controls on major change events. The fastest gains usually come from reducing backlog and standardising the smallest routine upgrade class.
What to verify: Verify that each application has an owner, an update cadence, and a documented threshold for when a dependency change becomes a higher-risk release. If those three things are missing, approvals tend to become arbitrary and slow.
Decision rule: If the update is security-focused, low impact, and covered by existing test evidence, treat it as routine maintenance. If it changes runtime behaviour, external interfaces, or validation assumptions, escalate it into the heavier change path.
Practitioner takeaway: The objective is not to approve every dependency update quickly, but to make the safe ones boring enough that the organisation can act before technical debt turns routine security work into an emergency.
Related resources from NHI Mgmt Group
Deepen Your Knowledge
Free weekly newsletter
Subscribe to the NHI & AI Identity Journal
The latest on NHI and Agentic AI security – articles, research, breaches, news and events every week.
Bonus 33% off our NHI Course when you subscribe.
Reviewed and updated by the NHIMG editorial team on October 12, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org